|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Scientific Meeting of European Scientists in Nanobiotechnology Cork/Ireland, Aug 10th, 2006. Main topics are the twelve strategic research projects (SRP) of Nano2Life: • Surface functionalisation and nano patterning • Protein, DNA and cell chips • Non-carbon nanotubes, nanoscale assemblies and self assemblies • In-vivo nano-imaging • In vivo cell and tissue analysis • Bioanalytics instrumentation • Cancer related nanodiagnostics • Nano-bio-info-cogno applied to neurodegenerative medicine • Cell biology • Environment monitoring and security • In vitro toxicology • Drug delivery including theranostics The SRP goal is to lay ground and built a platform of multidisciplinary research and development in nanobiotechnology, involving basic research and industry while supporting the general objectives of Nano2Life: • becoming an EU reference network in nanobiotechnology • transforming the SRP into European task forces in their specific areas of expertise Founded in 2004, N2L comprises 23 major European organizations and industrial companies within the field of nanobiotechnology as well as associate members from EU candidate countries, South Korea, Japan, Australia and North America.
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||